Nanotrons Corporation is a wholly owned subsidiary of Agiltron Inc. Nanotrons' vision is to leverage its proprietary advanced nano-engineering technologies to develop solutions to various 21st century challenges confronted by mankind related to energy, water, environment, and terrorism.
Commercializes nanoscale droplet technology being developed at the University of California, Irvine. The droplet technology provides high-precision, digital control of biochemical processes at the nanoscale.
Nanounity supplies surface science analytical solutions through a range of synergistic products through partnerships with leading instrumentation manufacturers. Their core technologies are microscopy, metrology and spectroscopy.
Nanovea manufactures Profilometers, Mechanical Testers & Tribometers to combine the most advanced testing capabilities in the industry: Scratch/Adhesion, Indentation/Hardness, Wear/Friction & 3D Non-Contact Metrology at Nano, Micro & Macro range. Unlike other manufactures Nanovea also provides Laboratory Services, offering clients availability to the latest technology and optimal results through improvements in testing standards.
An early stage therapeutic drug company, NanoVector Inc. is commercializing a patent pending nanoparticle drug delivery system developed at North Carolina State University. The NanoVector nanoparticle is a plant virus. Central to our technology, this virus, which has evolved over millions of years, has several inherent characteristics essential for a successful nanoparticle delivery system and superior to any designed and engineered by humans.
Nascentric has developed unique current-based technologies to address nanometer effects, and owns a diverse, valuable patent portfolio in this and many other unique verification and analysis techniques.